日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Mitigating the risk of venous thromboembolism in patients with multiple myeloma receiving immunomodulatory-based therapy

降低接受免疫调节治疗的多发性骨髓瘤患者发生静脉血栓栓塞的风险

期刊:Hematology-American Society of Hematology Education Program
影响因子:3.2
doi:10.1182/hematology.2022000414
Covut, Fahrettin; Sanfilippo, Kristen M
免疫/内分泌
多发性骨髓瘤
心血管
骨髓瘤
发表日期：2022
文献求助 收藏

Gastrointestinal Toxicities of Immune Checkpoint Inhibitors Are Associated With Enhanced Tumor Responsiveness and Improved Survival

免疫检查点抑制剂的胃肠道毒性与肿瘤反应增强和生存期延长相关

期刊:Gastroenterology Research
影响因子:1.7
doi:10.14740/gr1491
Alomari, Mohammad; Al Ashi, Suleiman; Chadalavada, Pravallika; Khazaaleh, Shrouq; Covut, Fahrettin; Al Momani, Laith; Elkafrawy, Ahmed; Padbidri, Vinay; Funchain, Pauline; Campbell, Donald; Romero-Marrero, Carlos
Checkpoint
肿瘤
肿瘤免疫
毒理研究
免疫/内分泌
发表日期：2022
文献求助 收藏

Significant costs and low utilization of stored peripheral blood stem cells for salvage autologous transplant in multiple myeloma patients including those meeting mSMART criteria

对于包括符合 mSMART 标准的患者在内的多发性骨髓瘤患者，储存的外周血干细胞用于自体挽救性移植的成本高昂且利用率低。

期刊:Bone Marrow Transplantation
影响因子:5.2
doi:10.1038/s41409-021-01223-y
Ahmed, Nausheen; Li, Lucy; Rojas, Patricio; Covut, Fahrettin; Reese-Koc, Jane; Kolk, Merle; Malek, Ehsan; Metheny, Leland; O'Brien, Timothy; Caimi, Paolo; de Lima, Marcos; Cooper, Brenda W
发育与干细胞
多发性骨髓瘤
骨髓瘤
干细胞
细胞生物学
发表日期：2021
文献求助 收藏

Tocilizumab for treatment of patients with severe COVID-19: A retrospective cohort study

托珠单抗治疗重症 COVID-19 患者：一项回顾性队列研究

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2020.100418
Kewan, Tariq; Covut, Fahrettin; Al-Jaghbeer, Mohammed J; Rose, Lori; Gopalakrishna, K V; Akbik, Bassel
发表日期：2020
文献求助 收藏

Evaluation of the United Kingdom-primary biliary cholangitis and global primary biliary cholangitis group prognostic models for primary biliary cholangitis patients treated with ursodeoxycholic acid in the U.S. population

对英国原发性胆汁性胆管炎和全球原发性胆汁性胆管炎组预后模型在美国人群中接受熊去氧胆酸治疗的原发性胆汁性胆管炎患者中的应用进行评估

期刊:JGH Open
影响因子:1.5
doi:10.1002/jgh3.12223
Alomari, Mohammad; Covut, Fahrettin; Al Momani, Laith; Chadalavada, Pravallika; Hitawala, Asif; Young, Mark F; Romero-Marrero, Carlos
发表日期：2020
文献求助 收藏

Significance of the absolute lymphocyte/monocyte ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma

淋巴细胞/单核细胞绝对比值作为新诊断多发性骨髓瘤预后免疫生物标志物的意义

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/bcj.2017.60
Dosani, T; Covut, F; Beck, R; Driscoll, J J; de Lima, M; Malek, E
多发性骨髓瘤
单核细胞
骨髓瘤
细胞生物学
免疫/内分泌
发表日期：2017
文献求助 收藏

Predicting Successful Phase Advancement and Regulatory Approval in Multiple Myeloma From Phase I Overall Response Rates

根据 I 期临床试验总体缓解率预测多发性骨髓瘤治疗的成功阶段推进和监管审批

期刊:JCO Clinical Cancer Informatics
影响因子:2.8
doi:10.1200/CCI.17.00055
Malek, Ehsan; Saygin, Caner; Ye, Rebecca; Covut, Fahrettin; Kim, Byung-Gyu; Welge, Jeffrey; Meropol, Neal J; De Lima, Marcos; Driscoll, James J
多发性骨髓瘤
骨髓瘤
发表日期：2017
文献求助 收藏